166 related articles for article (PubMed ID: 20883163)
1. Programmed death-1 affects suppressor of cytokine signaling-1 expression in T cells during hepatitis C infection.
Frazier AD; Zhang CL; Ni L; Ma CJ; Zhang Y; Wu XY; Atia AN; Yao ZQ; Moorman JP
Viral Immunol; 2010 Oct; 23(5):487-95. PubMed ID: 20883163
[TBL] [Abstract][Full Text] [Related]
2. Cross-talk between programmed death-1 and suppressor of cytokine signaling-1 in inhibition of IL-12 production by monocytes/macrophages in hepatitis C virus infection.
Zhang Y; Ma CJ; Ni L; Zhang CL; Wu XY; Kumaraguru U; Li CF; Moorman JP; Yao ZQ
J Immunol; 2011 Mar; 186(5):3093-103. PubMed ID: 21263070
[TBL] [Abstract][Full Text] [Related]
3. T cell dysfunction by hepatitis C virus core protein involves PD-1/PDL-1 signaling.
Yao ZQ; King E; Prayther D; Yin D; Moorman J
Viral Immunol; 2007; 20(2):276-87. PubMed ID: 17603844
[TBL] [Abstract][Full Text] [Related]
4. Tim-3 negatively regulates IL-12 expression by monocytes in HCV infection.
Zhang Y; Ma CJ; Wang JM; Ji XJ; Wu XY; Jia ZS; Moorman JP; Yao ZQ
PLoS One; 2011; 6(5):e19664. PubMed ID: 21637332
[TBL] [Abstract][Full Text] [Related]
5. Differential regulation of T and B lymphocytes by PD-1 and SOCS-1 signaling in hepatitis C virus-associated non-Hodgkin's lymphoma.
Yao ZQ; Ni L; Zhang Y; Ma CJ; Zhang CL; Dong ZP; Frazier AD; Wu XY; Thayer P; Borthwick T; Chen XY; Moorman JP
Immunol Invest; 2011; 40(3):243-64. PubMed ID: 21291295
[TBL] [Abstract][Full Text] [Related]
6. Impaired hepatitis B vaccine responses during chronic hepatitis C infection: involvement of the PD-1 pathway in regulating CD4(+) T cell responses.
Moorman JP; Zhang CL; Ni L; Ma CJ; Zhang Y; Wu XY; Thayer P; Islam TM; Borthwick T; Yao ZQ
Vaccine; 2011 Apr; 29(17):3169-76. PubMed ID: 21376795
[TBL] [Abstract][Full Text] [Related]
7. PD-1 negatively regulates interleukin-12 expression by limiting STAT-1 phosphorylation in monocytes/macrophages during chronic hepatitis C virus infection.
Ma CJ; Ni L; Zhang Y; Zhang CL; Wu XY; Atia AN; Thayer P; Moorman JP; Yao ZQ
Immunology; 2011 Mar; 132(3):421-31. PubMed ID: 21091911
[TBL] [Abstract][Full Text] [Related]
8. PD-1/PD-L1 signal pathway participates in HCV F protein-induced T cell dysfunction in chronic HCV infection.
Xiao W; Jiang LF; Deng XZ; Zhu DY; Pei JP; Xu ML; Li BJ; Wang CJ; Zhang JH; Zhang Q; Zhou ZX; Ding WL; Xu XD; Yue M
Immunol Res; 2016 Apr; 64(2):412-23. PubMed ID: 26286967
[TBL] [Abstract][Full Text] [Related]
9. Differential regulation of SOCS-1 signalling in B and T lymphocytes by hepatitis C virus core protein.
Yao ZQ; Prayther D; Trabue C; Dong ZP; Moorman J
Immunology; 2008 Oct; 125(2):197-207. PubMed ID: 18397267
[TBL] [Abstract][Full Text] [Related]
10. Functional restoration of HCV-specific CD8 T cells by PD-1 blockade is defined by PD-1 expression and compartmentalization.
Nakamoto N; Kaplan DE; Coleclough J; Li Y; Valiga ME; Kaminski M; Shaked A; Olthoff K; Gostick E; Price DA; Freeman GJ; Wherry EJ; Chang KM
Gastroenterology; 2008 Jun; 134(7):1927-37, 1937.e1-2. PubMed ID: 18549878
[TBL] [Abstract][Full Text] [Related]
11. PD-1 modulates regulatory T cells and suppresses T-cell responses in HCV-associated lymphoma.
Ni L; Ma CJ; Zhang Y; Nandakumar S; Zhang CL; Wu XY; Borthwick T; Hamati A; Chen XY; Kumaraguru U; Moorman JP; Yao ZQ
Immunol Cell Biol; 2011 May; 89(4):535-9. PubMed ID: 20975732
[TBL] [Abstract][Full Text] [Related]
12. Transient CD86 expression on hepatitis C virus-specific CD8+ T cells in acute infection is linked to sufficient IL-2 signaling.
Radziewicz H; Ibegbu CC; Hon H; Bédard N; Bruneau J; Workowski KA; Knechtle SJ; Kirk AD; Larsen CP; Shoukry NH; Grakoui A
J Immunol; 2010 Mar; 184(5):2410-22. PubMed ID: 20100932
[TBL] [Abstract][Full Text] [Related]
13. HCV-specific T cells in HCV/HIV co-infection show elevated frequencies of dual Tim-3/PD-1 expression that correlate with liver disease progression.
Vali B; Jones RB; Sakhdari A; Sheth PM; Clayton K; Yue FY; Gyenes G; Wong D; Klein MB; Saeed S; Benko E; Kovacs C; Kaul R; Ostrowski MA
Eur J Immunol; 2010 Sep; 40(9):2493-505. PubMed ID: 20623550
[TBL] [Abstract][Full Text] [Related]
14. High-programmed death-1 levels on hepatitis C virus-specific T cells during acute infection are associated with viral persistence and require preservation of cognate antigen during chronic infection.
Rutebemberwa A; Ray SC; Astemborski J; Levine J; Liu L; Dowd KA; Clute S; Wang C; Korman A; Sette A; Sidney J; Pardoll DM; Cox AL
J Immunol; 2008 Dec; 181(12):8215-25. PubMed ID: 19050238
[TBL] [Abstract][Full Text] [Related]
15. Restoration of HCV-specific T cell functions by PD-1/PD-L1 blockade in HCV infection: effect of viremia levels and antiviral treatment.
Urbani S; Amadei B; Tola D; Pedrazzi G; Sacchelli L; Cavallo MC; Orlandini A; Missale G; Ferrari C
J Hepatol; 2008 Apr; 48(4):548-58. PubMed ID: 18280607
[TBL] [Abstract][Full Text] [Related]
16. Synergistic reversal of intrahepatic HCV-specific CD8 T cell exhaustion by combined PD-1/CTLA-4 blockade.
Nakamoto N; Cho H; Shaked A; Olthoff K; Valiga ME; Kaminski M; Gostick E; Price DA; Freeman GJ; Wherry EJ; Chang KM
PLoS Pathog; 2009 Feb; 5(2):e1000313. PubMed ID: 19247441
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of PD-1 expression on circulating and intrahepatic hepatitis C virus-specific CD8+ T cells associated with reversible immune dysfunction.
Golden-Mason L; Palmer B; Klarquist J; Mengshol JA; Castelblanco N; Rosen HR
J Virol; 2007 Sep; 81(17):9249-58. PubMed ID: 17567698
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C virus core protein exerts an inhibitory effect on suppressor of cytokine signaling (SOCS)-1 gene expression.
Miyoshi H; Fujie H; Shintani Y; Tsutsumi T; Shinzawa S; Makuuchi M; Kokudo N; Matsuura Y; Suzuki T; Miyamura T; Moriya K; Koike K
J Hepatol; 2005 Nov; 43(5):757-63. PubMed ID: 16083990
[TBL] [Abstract][Full Text] [Related]
19. Bim-mediated apoptosis and PD-1/PD-L1 pathway impair reactivity of PD1(+)/CD127(-) HCV-specific CD8(+) cells targeting the virus in chronic hepatitis C virus infection.
Larrubia JR; Benito-Martínez S; Miquel J; Calvino M; Sanz-de-Villalobos E; González-Praetorius A; Albertos S; García-Garzón S; Lokhande M; Parra-Cid T
Cell Immunol; 2011; 269(2):104-14. PubMed ID: 21481848
[TBL] [Abstract][Full Text] [Related]
20. Abnormal B-cell activation associated with TALL-1 over-expression and SOCS-1 suppression during chronic hepatitis C virus infection.
Moorman J; Dong ZP; Ni L; Zhang C; Borthwick T; Yao ZQ
Immunology; 2009 Oct; 128(2):227-35. PubMed ID: 19740379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
